3',4'-Dihydroxyflavonol antioxidant attenuates diastolic dysfunction and cardiac remodeling in streptozotocin-induced diabetic m(Ren2)27 rats.
<h4>Background</h4>Diabetic cardiomyopathy (DCM) is an increasingly recognized cause of chronic heart failure amongst diabetic patients. Both increased reactive oxygen species (ROS) generation and impaired ROS scavenging have been implicated in the pathogenesis of hyperglycemia-induced l...
Guardado en:
Autores principales: | Fay Lin Khong, Yuan Zhang, Amanda J Edgley, Weier Qi, Kim A Connelly, Owen L Woodman, Henry Krum, Darren J Kelly |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b3c3d1f9a0624ba1b05fbec78e20252e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
3',4'-Dihydroxyflavonol reduces superoxide and improves nitric oxide function in diabetic rat mesenteric arteries.
por: Chen-Huei Leo, et al.
Publicado: (2011) -
Factors for remodeling and diastolic myocardial dysfunction in postmenopausal women with diabetes and hypertension
por: O S Elsukova, et al.
Publicado: (2013) -
Characterization of aging-associated cardiac diastolic dysfunction.
por: Wei-Ting Chang, et al.
Publicado: (2014) -
A novel electrocardiographic index for the diagnosis of diastolic dysfunction.
por: Mehdi Namdar, et al.
Publicado: (2013) -
Detection of subclinical atherosclerosis and diastolic dysfunction in patients with schizophrenia
por: &Uuml;nsal C, et al.
Publicado: (2013)